title: Safety and effectiveness of home intravenous antibiotic therapy for multidrug-resistant bacterial infections.
abstract: Home intravenous antibiotic therapy is an alternative to hospital admission for moderately severe infections. However, few studies have analyzed its safety and effectiveness in the treatment of infections caused by multidrug-resistant bacteria. The purpose of this study is to analyze the safety and effectiveness of home intravenous antibiotic therapy in multidrug-resistant bacterial infections. We analyzed prospectively all patients admitted to our service who underwent home intravenous antibiotic therapy during the period 2008-2012. All the treatments were administered by caretakers or self-administered by patients, through elastomeric infusion devices. Effectiveness was evaluated by analyzing the readmission rate for poor infection control. Safety was evaluated by analyzing adverse events, catheter-related complications, and readmissions not related to poor infection control. There were 433 admissions (in 355 patients) for home intravenous antibiotic therapy during the study period. There were 226 (52.2 %) admissions due to multidrug-resistant bacterial infections and 207 (47.8 %) due to non-multidrug-resistant infections. Hospital readmissions in patients with multidrug-resistant infections were uncommon. Multidrug-resistant enterococcal infections, healthcare-associated infections, and carbapenem therapy were independent variables associated with increased readmissions due to poor infection control. Readmissions not related to poor infection control, adverse events, and catheter-related complications were similar in multidrug-resistant compared to non-multidrug-resistant bacterial infections. Home intravenous therapy, administered by patients or their caretakers using elastomeric infusion pumps, was safe and effective for the treatment of most multidrug-resistant bacterial infections.
authors: Home Hospital Unit, Department of Internal Medicine, Sabadell Hospital, Corporació Sanitària Parc Taulí, Universitat Autònoma de Barcelona, Parc Taulí s/n, Sabadell, Barcelona, 08208, Spain, amujal@tauli.cat.
authors: A
authors: A
authors: Mujal
authors: J
authors: J
authors: Sola
authors: M
authors: M
authors: Hernandez
authors: M-A
authors: MA
authors: Villarino
authors: M-L
authors: ML
authors: Machado
authors: M
authors: M
authors: Baylina
authors: J
authors: J
authors: Tajan
authors: J
authors: J
authors: Oristrell
mesh_terms: D061605:Administration, Intravenous / Q000009:adverse effects; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D055499:Catheter-Related Infections / Q000453:epidemiology; D024901:Drug Resistance, Multiple, Bacterial; D064420:Drug-Related Side Effects and Adverse Reactions / Q000453:epidemiology; D005260:Female; D006699:Home Care Services; D006760:Hospitalization; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents
references: J Antimicrob Chemother. 2010 Jul;65(7):1510-3
references: 20460397
references: Clin Infect Dis. 2003 Jun 1;36(11):1433-7
references: 12766839
references: J Antimicrob Chemother. 2010 Apr;65(4):601-4
references: 20181573
references: Am J Infect Control. 2012 Mar;40(2):123-7
references: 21775020
references: J Infect Dev Ctries. 2009 May 01;3(4):295-9
references: 19759493
references: J Antimicrob Chemother. 2007 Aug;60(2):356-62
references: 17566002
references: BMC Infect Dis. 2013 Nov 06;13:523
references: 24195651
references: J Antimicrob Chemother. 2009 Sep;64(3):630-4
references: 19549671
references: Thorax. 2013 Nov;68(11):1007-14
references: 24130227
references: Am J Health Syst Pharm. 2006 Jul 1;63(13):1260-8
references: 16790578
references: Drugs. 1998 Mar;55(3):323-30
references: 9530540
references: Med Clin (Barc). 2012 May 12;138(13):557-61
references: 21621228
references: J Infect. 2004 Apr;48(3):263-8
references: 15001305
references: Am J Rhinol. 2007 Mar-Apr;21(2):154-8
references: 17424870
references: Enferm Infecc Microbiol Clin. 2009 May;27(5):257-62
references: 19386391
references: Med Clin (Barc). 2014 May 6;142(9):381-6
references: 23735867
references: Clin Infect Dis. 2004 Jun 15;38(12):1651-72
references: 15227610
references: J Microbiol Immunol Infect. 2009 Oct;42(5):401-4
references: 20182669
references: Clin Infect Dis. 2010 Sep 15;51 Suppl 2:S198-208
references: 20731577
references: Am J Infect Control. 2013 May;41(5):443-7
references: 22998785
references: Clin Infect Dis. 2014 Mar;58(6):812-9
references: 24357220
references: Ann Intern Med. 2002 Nov 19;137(10):791-7
references: 12435215